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Abstract
Background: Gestational diabetes mellitus (GDM) is a risk factor for diabetes mellitus. The 75-g, 2-h oral glucose
tolerance test is recommended for mothers with a history of GDM to screen for diabetes in the postnatal period.
The aim of this study was to investigate the rate of glucose screening within 6 months postpartum among Chinese
mothers with a history of GDM, and to identify its predictors.
Methods: A prospective cohort study was conducted in a regional teaching hospital in Guangzhou, China,
between July 2016 and June 2017. The participants were Chinese mothers (n = 237) who were diagnosed with
GDM, were aged 18 years or older with no serious physical or mental disease and had not been diagnosed with
type 1 or type 2 diabetes prior to their pregnancy. The revised Chinese version of the Champion’s Health Belief
Model Scale and social-demographic and perinatal characteristics factors were collected and used to predict
postpartum glucose screening (yes or no). Adjust odds ratio (AOR) and 95% confidence interval (95% CI) were
calculated.
Results: The mean age of the 237 mothers was 32.70 years (range from 22 to 44). Almost half of the mothers (45.
6%) were college graduates or higher. Chinese mothers reported a high level of perceived benefits, self-efficacy,
and health motivation towards postpartum glucose screening, with a mean score above 3.5.
Chinese mothers were more likely to undertake postpartum glucose screening if they were a first-time mother
[AOR 2.618 (95% CI: 1.398–4.901)], had a high perceived susceptibility score [AOR 2.173 (95% CI: 1.076–4.389)], a
high perceived seriousness score [AOR 1.988 (95%CI: 1.020–3.875)] and high perceived benefits score [AOR 2.978
(95%CI: 1.540–5.759)].
Conclusion: The results of this study will lead to better identification of mothers with a history of GDM who may
not screen for postpartum glucose abnormality. Health care professionals should be cognizant of issues that may
affect postpartum glucose screening among mothers with a history of GDM, including parity, perceived
susceptibility, perceived seriousness and perceived benefits.
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Background
Diabetes mellitus is a complex chronic condition with
serious physical, psychological, and clinical complica-
tions for the individuals affected [1]. Gestational diabetes
mellitus (GDM) is a risk factor for diabetes mellitus.
Mothers with a history of GDM are 7 times more likely
to develop type 2 diabetes mellitus later in life than
those without a history of GDM [2]. In fact, up to 70%
of mothers with a history of GDM will develop type 2
diabetes mellitus if there is no intervention [3]. In main-
land China, GDM has become one of the most common
complications during pregnancy. A recent survey of
15,194 Chinese pregnant women found that 19.7% of
them were diagnosed with GDM, which was higher than
the average morbidity worldwide [4].
Given the impact of prolonged undetected hypergly-
caemia, prevention and early diagnosis of diabetes is
cost-effective and important for public health [5–7]. It is
recommended that all mothers with a history of GDM
should screen for glucose in the postpartum period [8,
9]. This can help to detect glucose abnormality and then
provide early preventive interventions. Many mothers di-
agnosed with GDM however, do not undergo blood glu-
cose screening within the postnatal period [10–12]. One
report indicated that only 13.1% Chinese mothers (282
out of 2152) with a history of GDM were screened for
blood glucose in the postnatal period [10].
A number of international studies have suggested that
screening behaviour can be predicted by health beliefs
[13–15]. According to the Health Belief Model, health
beliefs refer to subjective feelings and cognition when
forming healthy behaviours. The Health Belief Model
consists of six constructs: perceived susceptibility, per-
ceived seriousness, perceived benefits, perceived barriers,
cues to action and self-efficacy [16]. The Health Belief
Model proposes that people must believe that, even in
the absence of any symptom, the disease may exist.
When people find themselves at risk of the disease (per-
ceived susceptibility), realize that the disease has serious
potential consequences (perceived seriousness), believe
that barriers of that behaviour (perceived barriers) are
less than the obtained benefits (perceived benefits), and
believe that they are able to undertake health behaviour
activities (self-efficacy), they are more likely to accom-
plish screening behaviour [17].
Apart from health beliefs, the literature shows that
other factors are associated with postpartum glucose
screening. These include socio-demographic charac-
teristics such as age, race, parity, income, education,
pre-pregnancy weight or body mass index (BMI)
[18–20] and perinatal characteristics which include
insulin use during pregnancy, medication use during
pregnancy, postpartum visits, and gestational weight
gain [11, 19, 21].
It is important to identify a set of factors associated
with postpartum glucose screening in mothers with a
history of GDM. Once identified, effective counselling
and promotion policies can be therefore implemented to
improve rates of postpartum glucose screening. How-
ever, limited evidence is available on the association be-
tween postpartum glucose screening and health beliefs
and other factors among mothers with a history of
GDM. This study aims to investigate the rate of the
postpartum glucose screening and identify its predictors
among Chinese mothers with a history of GDM.
Methods
Study design
A prospective cohort study was conducted.
Settings and participants
The study was carried out in Guangzhou, the capital of
Guangdong Province located in southeast China.
Guangzhou is classed as a first-tier city with a popula-
tion of around 16 million. More than half of the
employed women have received a tertiary education with
82.3% having a higher qualification in some Districts of
Guangzhou [22].
One leading hospital in Guangzhou was selected for
this study. The incidence rate of GDM in the study hos-
pital was 17% from 2013 to 2016, which is similar to the
average incidence of GDM in China in 2010 which was
17.5% [23]. The participating mothers were recruited
from 2106 mothers who gave birth between July and De-
cember 2016.
GDM is diagnosed based on the criteria of the Inter-
national Association of Diabetes and Pregnancy Study
Group (IADPSG), recommended by the Chinese Medical
Association [9]. The IADPSG criteria define GDM as a
fasting blood glucose (FPG) > 5.1 mmol/l, a 1-h glucose
level > 10.0 mmol/l or a 2-h glucose level > 8.5 mmol/l.
[9]. The mothers were recruited from the postnatal
wards of the study hospital. Mothers were eligible if they
were diagnosed with GDM, aged 18 years or older, had
given birth to a term (> 36 complete weeks of gestation)
singleton, with no serious physical or mental disease and
had not been diagnosed with type 1 or type 2 diabetes
prior to their pregnancy. Mothers were excluded if they
had multiple deliveries, had serious physical or mental
health conditions, had re-conceived within 6 months
postpartum or were diagnosed with type 1or type 2 dia-
betes mellitus prior to pregnancy.
Study factors
A revised Chinese version of the Champion’s Health Be-
lief Model Scale (RC-CHBMS) was used to measure
health beliefs. The original Chinese version of the
Champion’s Health Belief Model Scale was a scale
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adapted from Champion [24, 25] to measure beliefs re-
lated to liver cancer screening [26]. It was subsequently
revised to measure beliefs related to diabetes and post-
partum screening for diabetes. The RC-CHBMS has
been validated in Chinese women with a history of
GDM. Reported internal consistency for the scale was
0.833; the six subscales’ Cronbach’s alpha coefficients
ranged from 0.773 (motivation) to 0.806 (perceived
benefits) [27].
The RC-CHBMS is a 33-item instrument consisting of
6 subscales: perceived susceptibility (5 items), perceived
seriousness (6 items), perceived benefits (6 items), per-
ceived barriers (6 items), health motivation (5 items) and
self-efficacy (5 items). Each item was rated on a
five-point Likert scale ranging from “strongly disagree”
(1 point) to “strongly agree” (5 points). A higher ranking
on the Likert scale indicates a stronger agreement with
the health beliefs (for example, a higher benefit score in-
dicated perception of greater benefits and a higher bar-
rier score indicated a greater perception of barriers). All
subscales were positively related to postpartum screen-
ing for diabetes, except for barriers which were nega-
tively associated.
A self-designed social-demographic data sheet was
used to collect data on maternal age, marital status, edu-
cation, employment and family income, family history of
diabetes and pre-pregnancy body mass index (BMI). A
number of perinatal characteristics were collected, in-
cluding parity, gestational age at the diagnosis of GDM,
plasma glucose of OGTT during pregnancy, insulin ther-
apy during pregnancy, gestational weight gain, glucose
control during pregnancy, mode of delivery, infant feed-
ing method and childcare assistance.
After giving informed written consent, mothers were
asked to complete the RC-CHBMS and self-designed
social-demographic data sheet. Both RC-CHBMS and
social-demographic data sheet were collected within 4
days following the birth. Data on perinatal characteristics
were collected from the mothers’ medical record.
In mainland China, the recommended ranges for blood
glucose control for pregnant women with GDM are as fol-
lows: pre-prandial and fasting plasma glucose between 3.3
and 5.6 mmol/l (60–99mg/dl) and a 2-h post-prandial
plasma glucose between 5.6 and 7.1mmol/l (100–129mg/
dl). At each prenatal visit, the obstetrician checks the
self-monitoring record of every pregnant women with
GDM. If more than 70% of the self-monitored blood glu-
cose results reached the recommended level, blood glu-
cose control was considered acceptable. Blood glucose
control was considered good if more than 90% reached
the recommended level. If the pregnant women did not
meet the recommended blood glucose targets, an insulin
injection would be offered. If the insulin was rejected the
women would be offered oral hypoglycaemics.
Outcome measures and follow up
In this study, the postpartum glucose screening refers to
75-g, 2-h oral glucose tolerance test (OGTT) within 6
months postpartum based on the guidelines of the
American Diabetes Association and the Chinese Medical
Association [8, 9]. The World Health Organization [28]
criteria for diabetes, impaired glucose tolerance and im-
paired fasting glucose were used to assess the postpar-
tum glucose screening result: for diabetes: 2-h plasma
glucose of OGTT ≥11.1 mmol/l or fasting plasma glu-
cose ≥7.0 mmol/l; for impaired glucose tolerance: 2-h
plasma glucose between 7.8 and 11.0 mmol/l; for im-
paired fasting glucose: fasting plasma glucose between
6.1 and 6.9 mmol/l.
An online postpartum glucose screening data sheet
was used to collect the screening behaviour. The ques-
tions on the online postpartum glucose screening data
sheet included asking if a postpartum glucose screening
had been undertaken within 6 months postpartum (Yes
or No), the name of the hospital and the date of the
screening, and the methods used to detect glucose ab-
normality. Mothers were reminded to complete the data
sheet by a mobile-phone message. If the mother did not
reply, a follow–up phone call was made within 2 weeks.
If a mother had the postpartum glucose screening in the
study hospital, the results were retrieved from her med-
ical record. If screening was done at other hospitals or
clinics, the results were obtained from the mother.
Statistical analysis
Descriptive statistics were used to present demographic
and perinatal characteristics and the health beliefs. Some
continuous variables such as age and health beliefs were
categorised/dichotomised using clinical reference values
or median values [29]. The mothers who had scores
higher than the median on the 6 subscales were classi-
fied as having high level of health beliefs. Differences in
rate of postpartum glucose screening among groups with
different level of health beliefs, socio-demographic and
perinatal characteristics were compared using the
chi-squared test. Variables with p < 0.1 in the above tests
were input into the multivariable logistic regression
model to determine the predictors of the postpartum
glucose screening. Maternal age and BMI were adjusted
in multivariable analyses. Odds ratio (OR), adjusted odds
ratio (AOR) and 95% confidence interval (95% CI) were
calculated. Data analysis was performed using SPSS 22.0
for Windows (SPSS Inc., Chicago, IL, USA).
Results
Demographic and perinatal characteristics
During the recruitment period, there were 357 mothers
whose pregnancy was complicated with GDM. Of these,
294 met inclusion criteria. Twenty-six mothers (8.8%)
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refused to participate, 31 (10.5%) were lost to follow-up
or withdrew from the study. At 6 months follow-up, 237
mothers finished the questionnaires (Fig. 1). There were
no differences in socio-demographic characteristics be-
tween the mothers who completed the study and those
who did not.
Table 1 presents the demographic characteristics of the
mothers. The mean age of the mothers was 32.70 y (SD =
4.59, range = 22–44). Almost half of the mothers (45.6%)
were college graduates or higher. More than one third of
the mothers (35.9%) had a monthly household income > ¥
9000 (US$1327), which was above the average monthly
household income in Guangzhou [30] (Additional file 1).
Table 2 presents the perinatal characteristics of
mothers. In this study, half of the mothers (52.7%) had
good glycaemic control during their pregnancy. How-
ever, only 7 mothers used insulin and 35 used oral
agents to control blood glucose during pregnancy. Al-
most one fourth of the mothers (24.9%) had a family his-
tory of diabetes. More than half of the mothers (66.7%)
exclusively breastfed their babies within the 6-month
postpartum period. Childcare assistance was present for
62.9% of mothers.
Health beliefs
Table 3 presents the mean item score and the median
score of the 6 subscales of the RC-CHBMS in descend-
ing order. The mothers had a high level of perceived
benefits, self-efficacy and health motivation with the
mean item score above 3.5 on these three subscale. Less
than half of the mothers had a high level of perceived
benefits (49.8%); self-efficacy (40.9%); health motivation
(43.5%) and perceived barriers (48.9%). Only one third of
the mothers (33.8%) had a high level of perceived ser-
iousness of diabetes mellitus; while two thirds of the
mothers had a high level of perceived susceptibility.
Postpartum glucose screening
Of the 237 mothers, 91 had postpartum glucose screen-
ing, which presents a postpartum glucose screening rate
Fig. 1 Flowchart of recruitment and loss to follow-up for the study
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of 38.4%. Of the 91 mothers, 3 (3.3%) were classified
with impaired fasting glucose, 24 (26.4%) with impaired
glucose tolerance and 1 (1.1%) with diabetes. In addition,
24.5% (58 of the 237) mothers reported that they had
monitored their finger stick capillary blood glucose ir-
regularly at home.
Mothers were more likely to have postpartum glucose
screening if they were first-time mothers [OR 2.153, 95%
CI (1.257, 3.687)], or they had a family history of dia-
betes [OR 2.320, 95% CI (1.266, 4.250)] (Table 4).
Mothers with high level of perceived benefits [OR 4.772,
95% CI (2.695, 8.451)], high level of perceived serious-
ness [OR 3.102, 95% CI (1.773, 5.430)], or high level of
perceived susceptibility [OR 3.550, 95% CI (1.962,
6.422)] were more likely to undertake postpartum glu-
cose screening. Blood glucose management during preg-
nancy was not related to postpartum glucose screening.
Variables that had significant correlation with postpar-
tum glucose screening were retained in the logistic regres-
sion model. The best-fit regression model revealed 4
variables predicting postpartum glucose screening, includ-
ing first-time mother [OR 2.618 (95% CI: 1.398–4.901)],
high perceived susceptibility score [OR 2.173 (95% CI:
1.076–4.389)], high perceived seriousness score [OR 1.988
(95%CI: 1.020–3.875)] and high perceived benefits score
[OR 2.978 (95%CI: 1.540–5.759)] (Table 5).
Discussion
According to our knowledge, this is the first study to ex-
plore the predictors of postpartum glucose screening
among Chinese mothers with a history of GDM based
on the Health Belief Model. The findings of the present
study confirm the evidence that mothers with a history
of GDM have a high risk for abnormal glucose regula-
tion [2, 4, 31]. Therefore, all mothers with a history of
GDM should have postpartum glucose screening. How-
ever, in the present study, only 91 (38.4%) of 237
Table 1 Demographic characteristics of the mothers (n = 237)
Characteristics n %
Ages (years)
< 30 62 26.2
30–34 95 40.1
≥ 35 80 33.8
Education
Senior high school or less 53 22.4
Junior college 76 32.1
College graduate 68 28.7
Graduate degree or above 40 16.9
Monthly family income
< ¥5000 (about US$737) 37 15.6
¥5000–¥9000 (about US$737–US$1327) 115 48.5
> ¥9000 (aboutUS$1327) 85 35.9
Family history of diabetes
No 164 69.2
Yes 59 24.9
Not known 14 5.9
Pre-pregnancy BMI (kg/m2)
< 18.5 38 16.0
18.5–24.9 165 69.6
≥ 25.0 34 14.3
Table 2 Perinatal characteristics of the mothers (n = 237)
Characteristics n %
Parity
1 93 39.2
≥ 2 144 60.8
Gestational age when diagnosed with gestational diabetes mellitus
(weeks)
< 24 14 5.9
24–28 200 84.4
> 28 23 9.7
Gestational diabetes mellitus diagnostic OGTT glucose (mmol/l) (Mean
± S.D.)
Fasting plasma glucose 4.59 ± 0.65
1-h plasma glucose 9.90 ± 1.60
2-h plasma glucose 9.07 ± 1.40
Management of gestational diabetes mellitus
Diet or physical activity 195 82.3
Oral agents 35 14.8
Insulin injection 7 3.0
Blood glucose control during pregnancy
Acceptable or good 125 52.7
Not good 70 29.5
Data were unavailable 42 17.7
Gestational weight gain
Less than the recommended 122 51.5
Within the range of the recommended 91 38.4
More than the recommended 24 10.1
Mode of delivery
Spontaneous vaginal birth or vacuum 146 61.6
Caesarean section 91 38.4
Infant feeding method
Exclusive breastfeeding 158 66.7
Mixed feeding 69 29.1
Formula feeding 10 4.2
Having someone help with childcare
Yes 149 62.9
No 88 37.1
OGTT Oral glucose tolerance test
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Table 3 The mothers’ scores on the subscales of the RC-CHBMS (n = 237)
Variables Mean ± SD Median Number and percent > median (High) Number and percent≤median (Low)
Perceived benefits 3.83 ± 0.29 3.83 118 (49.8%) 119 (50.2%)
Self-efficacy 3.75 ± 0.36 3.60 97 (40.9%) 140 (59.1%)
Health motivation 3.68 ± 0.32 3.80 103 (43.5%) 134 (56.5%)
Perceived seriousness 2.75 ± 0.37 2.83 80 (33.8%) 157 (66.2%)
Perceived susceptibility 2.63 ± 0.49 2.60 144 (60.8%) 93 (39.2%)
Perceived barriers 1.73 ± 0.35 1.67 116 (48.9%) 121 (51.1%)
Table 4 Differences in rates of postpartum glucose screening between the mothers with high level of health beliefs and low level
of health beliefs; and among the various socio-demographic and perinatal sub-groups (n = 237)
Characteristics Postpartum Glucose screening
Yes
(n = 91)
No
(n = 146)
OR (95% CI)
Parity
1 46 (49.5) 47 (50.5) 2.153 (1.257, 3.687)
≥ 2 45 (31.2) 99 (68.8) Ref.
Family history of diabetes
Yes 33 (55.9) 26 (44.1) 2.320 (1.266, 4.250)
No 58 (35.4) 106 (64.6) Ref.
Not known 0 (0.0) 14 (100.0) 0.000
Mode of delivery
Spontaneous vaginal birth or vacuum 63 (43.2) 83 (56.8) 1.708 (0.983, 2.968)a
Caesarean section 28 (30.8) 63 (69.2) Ref.
Having someone help with childcare
Yes 64 (43.0) 85 (57.0) 1.701 (0.974, 2.970)a
No 27 (20.7) 61 (69.3) Ref.
Perceived benefits
Low 25 (21.0) 94 (79.0) Ref.
High 66 (55.9) 52 (44.1) 4.772 (2.695, 8.451)
Self-efficacy
Low 52 (37.1) 88 (62.9) Ref.
High 39 (40.2) 58 (59.8) 1.138 (0.669, 1.936)
Health motivation
Low 46 (34.3) 88 (65.7) Ref.
High 45 (43.7) 58 (56.3) 1.484 (0.875, 2.517)
Perceived seriousness
Low 46 (29.3) 111 (70.7) Ref.
High 45 (56.2) 35 (43.8) 3.102 (1.773, 5.430)
Perceived susceptibility
Low 20 (21.5) 73 (78.5) Ref.
High 71 (49.3) 73 (50.7) 3.550 (1.962, 6.422)
Perceived barriers
Low 51 (42.1) 70 (57.9) 1.384 (0.818, 2.343)
High 40 (34.5) 76 (65.5) Ref.
ap < 0.1
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mothers underwent this screening within 6 months post-
partum, which was lower than the rates from Japan and
Singapore. Kugishima et al. [11] reported that 65.7% of
Japanese mothers with a history of GDM underwent
postpartum glucose screening within 6 to 8 weeks post-
partum. Suan [20] reported that 81.9% of Singaporean
mothers with a history of GDM performed postpartum
glucose screening within 6 to 8 weeks postpartum.
The lower rate of postpartum glucose screening in the
present study may be related to the fact that mothers
with a history of GDM were not advised to undertake
postpartum glucose screening during pregnancy and
were also not reminded to do so after discharge from
the hospital. Currently, in mainland China healthcare
professionals tend to assume that GDM disappears after
delivery. Whilst occupied with caring for the baby they
neglect to inform the pregnant women to screen for
blood glucose abnormality after the birth [10]. It was
only when a mother with GDM remained in the hospital
after birth, that postpartum screening for diabetes by an
obstetric nurse in the postnatal ward was recommended.
Following discharge from hospital community nurses
visited mothers with GDM twice within the first month
postpartum, focusing on breastfeeding and the mothers’
physical recovery. Community nurses are not asked to
remind these mothers to screen for diabetes as part of
standard care [32].
Chang et al. [10] suggests that a reminder from health pro-
fessionals is a key reason mothers with a history of GDM
undertake postpartum glucose screening. A Cochrane litera-
ture review found that a reminder system for mothers with a
history of GDM could increase the rate of postpartum glu-
cose screening [33]. The findings of the present study indi-
cate that there is an urgent need for postnatal healthcare
professionals to remind mothers with a history of GDM to
undertake postpartum glucose screening. A reminder system
incorporating alerts into the mothers’ electronic medical re-
cords could be established, along with short text messages,
emails or telephone calls as reminders.
Interestingly, there were 58 (24.5%) mothers with a
history of GDM who monitored their finger stick capil-
lary blood glucose irregularly by themselves. The finger
test is however affected by temperature, humidity, oper-
ating practice and is not recommended to detect im-
paired fasting plasma and impaired glucose tolerance
[34, 35]. The OGTT is more sensitive at 100% compared
with 67% for the fasting plasma glucose test [34]. Both
the Chinese Medical Association [9] and American Dia-
betes Association [8] recommend the OGTT as the
standard method of postpartum screening for diabetes.
Considering that the mothers in the present study had a
high level of health motivation and perceived less bar-
riers to diabetes screening, one explanation for this find-
ing may be due to mothers’ lack of knowledge about the
OGTT as the standard method of screening for diabetes.
The findings of the present study suggested that health-
care professionals should not only remind the mothers
to have postpartum glucose screening, but should also
inform them that the OGTT is the standard method
used to screen for glucose abnormality in the postpar-
tum period.
The present study also found that parity predicted a
woman’s motivation to attend for postpartum glucose
screening. First-time mothers were more likely to screen
for glucose abnormality than those who had more than
one child. This was consistent with previous studies
where mothers who had more children were less likely
to screen for glucose abnormality in the postpartum
period [19, 31, 35]. Mothers with only one baby have
relatively more available time for postpartum glucose
screening than those who have more than one child
which may account for this [36, 37].
Concerning the Health Belief Model, mothers with a
history of GDM who perceived higher susceptibility to
diabetes, perceived seriousness of diabetes and higher ben-
efits of postpartum screening for diabetes were more likely
to undertake postpartum glucose screening. This finding
is consistent with the Health Belief Model [15] and studies
Table 5 Predictors of postpartum glucose screening within 6 months postpartum among Chinese mothers with a history of
gestational diabetes mellitus (n = 237)
Variables B wald p Adjusted
OR
95%CI
Lower Upper
Paritya
1 0.962 9.043 0.003** 2.618 1.398 4.901
≥ 2 Reference
Perceived susceptibility 0.776 4.678 0.031* 2.173 1.076 4.389
Perceived seriousness 0.687 4.077 0.043* 1.988 1.020 3.875
Perceived benefits 1.091 10.517 0.001** 2.978 1.540 5.759
Adjusted for maternal age, pre-pregnancy body mass index, family history of diabetes, mode of delivery, childcare, perceived susceptibility, perceived seriousness
and perceived benefits
aParity: 1 = primipara, ≥ 2 =multipara
*p < 0.05, **p < 0.01
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on breast cancer screening [38]. Chang et al. [10] further
indicated that a woman’s belief that GDM would dis-
appear after delivery was the second highest occurring
reason for not performing postpartum glucose screening.
Mothers with a history of GDM have a moderate level
of perceived susceptibility and perceived seriousness to
diabetes and may not realize the risks subsequent dia-
betes. This may be another reason why many mothers
with a history of GDM in the present study did not
undertake postpartum glucose screening. This finding
was consistent with a previous study, in which 74% of
Australian mothers with a history of GDM did not per-
ceive themselves at high or very high risk for developing
diabetes in the future [39]. The findings of the present
study suggested that an education program with a strong
focus on perceived susceptibility and perceived serious-
ness to diabetes and the benefits of postpartum glucose
screening may improve the uptake of such screening
among the mothers with a history of GDM.
In relation to the management of their GDM, the
present study found that only a small percent of pregnant
women managed their blood glucose by insulin injection
or oral medicine. Almost one third of the mothers did not
effectively manage blood glucose during pregnancy. Only
3% of the mothers (n = 7) managed their blood glucose
through the injection of insulin and 14.8% (n = 35) by oral
medicine. This may be because most Chinese pregnant
women with GDM are resistant when treatment with in-
sulin injection or oral agents is advised [40]. Insulin injec-
tion is perceived as inconvenient and women fear the side
effects of oral agents on the foetus. Moreover, some of
them may mistakenly believe that they have to rely on in-
sulin on an ongoing basis once it has been used initially
[40]. The findings of the present study are consistent with
a previous study which suggested that health care profes-
sionals should put more effort into helping pregnant
women with a history of GDM to understand how to
manage GDM correctly, especially regarding insulin injec-
tion and oral medicine [41].
This study had some limitations. The study was con-
ducted in one hospital. The majority of mothers were
middle class women with a high-level of education [30].
Our findings may not be transferable to other settings or
to women from a different social class, with lower levels
of education or to rural women.
Conclusion
This study has significant clinical utility for health care
professionals working with Chinese mothers with a his-
tory of GDM. To identify mothers who may not undergo
postpartum glucose screening, health care professionals
are advised to assess a mother’s parity, health beliefs in
relation to perceived susceptibility, perceived seriousness
and perceived benefits. Health care professionals could
develop strategies following assessment to encourage
these mothers to undergo postpartum glucose screening.
These strategies for example could be establishing a re-
minder system and providing education focused on the
risk and seriousness of GDM for diabetes and the bene-
fits of postpartum glucose screening.
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